Displaying posts published in

September 2015

Pulling Our Strings and Poking Us in the Eyes: The Ahmed Mohamed Fairy Tale By Clarice Feldman

There can be no doubt that Americans are fortunate enough to be governed by a brilliantly conceived Constitution drafted by remarkable, intelligent men. Unfortunately, too many Americans are utterly ignorant of what it contains and how it impacts on their lives. Voter ignorance on this and so much else contributes to the ease with which the media manipulates public opinion into believing things which are not so. In this they play into the hands of a childishly narcissistic president who despises the values upon which our country was based, a man who repeatedly pokes our allies and us in the eyes to show that he can deeply offend without penalty.

1) The appalling ignorance of American voters.

A recent survey by the Annenberg Public Policy Center of the University of Pennsylvania found that a majority of Americans are unaware of what is considered basic knowledge of the Constitution.

This information, which was released Wednesday, comes on the cusp of the 228th anniversary of Constitution Day (Sept. 17).

Here are some of the most surprising findings from the survey

• 1 in 3 Americans believe the Bill of Rights guarantees the right to home ownership.

• 1 in 4 Americans believe the Bill of Rights guarantees “equal pay for equal work.”

• 1 in 3 Americans (31 percent) could name all three branches of the U.S. government and 32 percent could not identify a single branch.

• 1 in 4 Americans (28 percent) believe a 5-4 Supreme Court ruling is sent back to either Congress for reconsideration or to the lower courts for another decision.

• 1 in 10 Americans (12 percent) believe the Bill of Rights guarantees the right to own a pet.

• 25 percent of respondents agreed that “it might be better to do away with the court altogether” if it started making a lot of rulings most Americans disagreed with.

• 26 percent said when Congress disagrees with the Supreme Court’s decisions, it should pass legislation saying the court can no longer rule on that issue.

• 26 percent favored requiring a person to testify against himself in court.

RUTHIE BLUM INTERVIEWS SANDOR FRANKEL, THE TRUSTEE TASKED WITH DISTRIBUTIN LEAONA HELMSLEY’S BILLIONS

Renowned New York attorney Sandor (Sandy) Frankel, one of four trustees of the Leona M. and Harry B. Helmsley Charitable Trust, was in Israel earlier this month to look at additional philanthropic options and to observe the progress of those endeavors already funded – to the tune of multi-millions.

Frankel, who recently joined the prestigious Park Avenue law firm Otterbourg P.C., met with Israeli politicians and other bigwigs to get a sense from them about which projects in the country need the most attention.

Over the course of the last seven years or so, the Helmsley Trust has donated in the ballpark of $145 million in grants (out of overall assets of over $5 billion) to works in and related to the Jewish state. Among these are: a joint grant to the Technion and the Weizmann Institute for alternative-energy research ($15 million); multi-million-dollar grants to the Weizmann Institute for stem-cell research and a sophisticated MRI for Crohn’s disease diagnosis; a new blood bank for Magen David Adom ($8 million); a grant to Haifa University for a Mediterranean Sea research center ($7 million); funding for an underground facility that converts a parking garage at the Rambam Medical Center in Haifa into a 2,000-bed, bomb-proof facility for war-time ($5 million); the Jerusalem Press Club facilities in Mishkenot Sha’ananim; Birthright trips; and a grant for a robotics project at Ben-Gurion University in the Negev ($6.3 million).

GOOD NEWS FROM AMAZING ISRAEL

www.verygoodnewsisrael.blogspot.com
ISRAEL’S MEDICAL ACHIEVEMENTS

Liver cancer treatment gets on the fast track. The FDA has granted fast track designation to the CF102 treatment from Israel’s Can-Fite BioPharma for hepatocellular carcinoma (HCC), the most common form of liver cancer. A CF102 trial is about to start on 78 patients with Child-Pugh Class B cirrhosis, who failed the only FDA approved treatment on the market – Nexavar.
http://biotuesdays.com/2015/09/17/can-fite-gets-fda-fast-track-for-liver-cancer-drug/

A smarter bed. Israel’s EarlySense is launching its “smart bed” solution myEarlySense. The “under the mattress” sensors record data on how you are sleeping, such as tossing, turning, waking, sleeping, breathing and heart rates. It can also turn on heaters and make the coffee.
http://www.timesofisrael.com/smart-bed-lets-you-sleep-better-and-makes-coffee-too/
https://www.youtube.com/watch?v=vZPRv6BAeJs

South Africa buys Israeli virus testing system. Israel’s Ilex Medical has won a tender issued by the South African National Blood Service (SANBS) for its Panther blood testing systems to detect and identify viruses.
http://www.globes.co.il/en/article-ilex-medical-wins-huge-south-african-tender-1001068697

IBM and Teva team up to find chronic treatments. IBM Israel has granted Israel’s Teva access to its Watson supercomputing Health Cloud program. Teva plans to use the global technology platform to design treatments for millions of people who suffer from chronic conditions like asthma, migraine, and pain.
http://www.globes.co.il/en/article-teva-ibm-partnership-to-seek-big-data-health-solutions-1001068493

Opening up a new strategy for HIV. Technion scientists have discovered that when the HIV virus encounters resistance, it looks for detours. It then mutates and replicates itself, like a Trojan horse, exploiting redundancy in the DNA of host cells. http://www.technion.ac.il/en/2015/08/new-strategy-for-hiv/

Detecting cancer using nanopores. Further to a previous (15 Mar 2015) newsletter, scientists from Israel’s Technion are the only team working for European research consortium BeyondSeq on early diagnosis of cancer. They are using tiny silicon “nanopore” scanners to detect molecular DNA biomarkers in cancer cells.
http://pard.technion.ac.il/2015/09/09/researchers-use-nanopore-scanners-to-find-early-signs-of-cancer/
http://cordis.europa.eu/project/rcn/193312_en.html

Genetic test for BRONJ. (TY Atid-EDI) Israel’s Micromedic Technologies, has identified several new genetic markers for predicting BRONJ (necrosis of the jawbone). BRONJ is a side effect of intravenous treatments in cancer and osteoporosis patients.
http://www.bio-light.co.il/wp-content/uploads/2015/08/BRONJ-PR-clean-updated.pdf
http://biotuesdays.com/2015/08/31/biolight-unit-identifies-bronj-genetic-markers/

Microneedles deliver vital vaccines. (TY Atid-EDI) Israel’s NanoPass Technologies is supplying its MicronJet600 microneedle system to US-based Immune Design who will use the system to deliver vaccines to cancer immunotherapy patients.
http://www.prnewswire.com/news-releases/nanopass-technologies-to-supply-micronjet600-device-to-immune-design-for-use-in-zvex-based-oncology-immunotherapy-products-525620521.html

Israel ranks 6th in Healthy Life Expectancy. (TY Atid-EDI) The World Health Organization (WHO) ranks Israel 6th in the world, with the average Israeli living without a terminal illness to age 71.5. Israeli men have the world’s fourth longest total life expectancy of 80.2 years. For women, Israel is ranked tenth with a total life expectancy of 84 years. http://www.ynetnews.com/articles/0,7340,L-4696329,00.html

IBM Haifa’s diagnostic apps. More about the app developed by IBM Haifa to diagnose ADHD sufferers (see Sep 6 2015 newsletter). It won top prize at the Brain Inspired Technology for Education (BITE) Hackathon at Israel’s Technion Institute. Also describes IBM Haifa’s dementia early-detection app (Aug 9 2015 newsletter).
http://www.israel21c.org/diagnostic-apps-for-adhd-dementia/